NSE filing, NSE: ABDL. Summary written from the filing by ALFA Finder's alert engine.
Allied Blenders & Distillers Ltd: key numbers
- Share price
- ₹702.20
- Market cap
- ₹19,641 Cr
- Revenue (annual)
- ₹3,923 Cr
- Net profit (annual)
- ₹228.3 Cr
- P/E (TTM)
- 86.1×Sector 26.2×
- Promoter holding
- 78.95%-1.96% QoQ
- FII holding
- 4.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Allied Blenders & Distillers Ltd
All →Allied Blenders & Distillers Earnings Call Transcript: Key Takeaways
ABD achieved record quarterly volumes crossing 10 million cases, driven by aggressive premiumization and the turnaround of flagship brands in key Southern markets.
- Call
- Guides 15% growth
Allied Blenders & Distillers Investor Presentation: Key Takeaways
Q2FY27 revenue ₹1,152 Cr (+15.8%), EBITDA ₹143 Cr (+10.0%), margin 12.4% (-66 bps), PAT ₹69 Cr (+9.7%). Record 10.0 Mn case volume; premiumisation and P&A-led strategy.
Allied Blenders & Distillers Results Update
Allied Blenders reported Q2FY27 income from operations of ₹1,152 crore, up 15.8% YoY, with PAT of ₹69 crore. Record volumes and newly commissioned plants supported the growth.
Allied Blenders & Distillers Management Change
Allied Blenders re-appointed Balaji Swaminathan as Independent Director for five years from February 2027. The board also sought shareholder approval via postal ballot.
Allied Blenders & Distillers Q2 FY27 Results: Net Profit ₹69 Cr, Up 9.7% YoY
Allied Blenders & Distillers Ltd reported revenue from operations of ₹2,086 Cr (+6.8% YoY) and net profit of ₹69 Cr (+9.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹69 Cr · +9.7% YoY
Allied Blenders & Distillers ED Probe / Tax Survey
Allied Blenders and Distillers reported a DRI visit regarding an industry-wide HSN code review for bulk Scotch imports. The company confirms no material financial or operational impact.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date